The relationship between glucose metabolism disorders and malignant thyroid disease

International Journal of Clinical Oncology

Volumn 18, Issue 4, 2013, Pages 585-589

  Duran, Ayse Ocak ^c   Anil, Cüneyd ^a   Gursoy, Alptekin ^b   Nar, Asli ^a   Altundag, Ozden ^a   Tutuncu, Neslihan Bascil ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b GÜVEN HOSPITAL   (Turkey)

^c ERCIYES UNIVERSITY   (Turkey)

Author keywords

Glucose metabolism disorders; Thyroid cancer

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CYTOLOGY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; GLUCOSE METABOLISM; HUMAN; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROID CANCER; THYROID NODULE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; FEMALE; GLUCOSE METABOLISM DISORDERS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROID NODULE; THYROTROPIN; YOUNG ADULT;

EID: 84882716813     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-012-0435-3     Document Type: Article

References (27)

1. Gursoy A (2010) Rising thyroid cancer incidence in the world might be related to insulin resistance. Med Hypotheses 74:35-36
2. Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167
3. Leenhardt L, Grosclaude P, Cherie-Challine L (2004) Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14:1056-1060
4. Lubina A, Cohen O, Barchana M et al (2006) Time trends of incidence rates of thyroid cancer in Israel: what might explain the sharp increase. Thyroid 16:1033-1040
5. AACE/AME Task force on Thyroid Nodules (2006) American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 12:63-100
6. American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33:62-69
7. Grote VA, Becker S, Kaaks R (2010) Diabetes mellitus type 2 - an independent risk factor for cancer. Exp Clin Endocrinol Diabetes 118:4-8
8. Friberg E, Orsini N, Mantzoros CS et al (2006) Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 50:1365-1374
9. Huxley R, Ansary-Moghaddam A, Berrington de González A et al (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92:2076-2083
10. Larsson SC, Orsini N, Wolk A (2005) Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97:1679-1687
11. Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121:856-862
12. Mori M, Saitoh S, Takagi S et al (2000) A review of cohort studies on the association between history of diabetes mellitus and occurrence of cancer. Asian Pac J Cancer Prev 1:269-276
13. Pisani P (2008) Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem 114:63-70
14. Jee SH, Ohrr H, Sull JW et al (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293:194-202
15. Rapp K, Schroeder J, Klenk J et al (2006) Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 49:945-952
16. Stattin P, Bjor O, Ferrari P et al (2007) Prospective study of hyperglycemia and cancer risk. Diabetes Care 30:561-567
17. Mink PJ, Shahar E, Rosamond WD et al (2002) Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol 156:349-352
18. Inoue M, Iwasaki M, Otani T et al (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166:1871-1877
19. Stolzenberg-Solomon RZ, Graubard BI, Chari S et al (2005) Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA 294:2872-2878
20. Kabat GC, Kim M, Caan BJ et al (2009) Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int J Cancer 125:c2704-c2710
21. Rezzónico JN, Rezzónico M, Pusiol E et al (2009) Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metab Syndr Relat Disord 7:375-380
22. Rezzonico J, Rezzonico M, Pusiol E et al (2008) Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid 18:461-464
23. Vella V, Sciacca L, Pandini G et al (2001) The IGF system in thyroid cancer: new concepts. Mol Pathol 54:121-124
24. Ciampolillo A, De Tullio C, Perlino E et al (2007) The IGF-I axis in thyroid carcinoma. Curr Pharm Des 13:729-735
25. Rapoport B, Chazenbalk GD, Jaume JC et al (1998) The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev 19:673-716
26. Boelaert K, Horacek J, Holder RL et al (2006) Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 91:4295-4301
27. Enewold L, Zhu K, Ron E et al (2009) Rising thyroid cancer incidence in the United States by demographic and tumor characteristics 1980-2005. Cancer Epidemiol Biomarkers Prev 18:784-791